Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,757 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,046)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01576796 | Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer(RTEP-5) | unknown | Phase 2 | 75 | Centre Henri BecquerelOTHER | 1 | Jul 28, 2016 | clinicaltrials |
| NCT02841228 | Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer | unknown | Phase 2 | 40 | Hunan Province Tumor HospitalOTHER | 1 | Jul 22, 2016 |
| clinicaltrials |
| NCT00697333 | Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC(PET-Plan) | unknown | Phase 2 | 200 | Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGNOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT02820116 | The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation | unknown | Phase 2 | 67 | Beijing Haidian HospitalOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT01803503 | Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors | unknown | Phase 2 | 80 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02788058 | A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy | unknown | Phase 2 | 76 | First People's Hospital of HangzhouOTHER | 0 | Jun 2, 2016 | clinicaltrials |
| NCT02651441 | D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) | unknown | Phase 1 / Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 24, 2016 | clinicaltrials |
| NCT02780778 | Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 23, 2016 | clinicaltrials |
| NCT02766348 | Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients | unknown | Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 9, 2016 | clinicaltrials |
| NCT02738983 | RT Plus EGFR-TKI for Wild-type NSCLC | unknown | Phase 2 | 22 | Hangzhou Cancer HospitalOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02733107 | The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 25 | Third Military Medical UniversityOTHER | 1 | Apr 12, 2016 | clinicaltrials |
| NCT00690963 | Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating | unknown | Phase 1 / Phase 2 | 12 | AHS Cancer Control AlbertaOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT02037997 | Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC | unknown | Phase 2 | 80 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT02669719 | Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC | unknown | Phase 2 | 70 | Shanghai Chest HospitalOTHER | 1 | Feb 1, 2016 | clinicaltrials |
| NCT02650544 | Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression | unknown | Phase 2 | 236 | Sun Yat-sen UniversityOTHER | 1 | Jan 8, 2016 | clinicaltrials |
| NCT00973310 | Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer | unknown | Phase 2 | 50 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01660399 | Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy | unknown | Phase 2 | 300 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02631460 | S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC | unknown | Phase 2 | 470 | Sun Yat-sen UniversityOTHER | 1 | Dec 16, 2015 | clinicaltrials |
| NCT01494415 | Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer | unknown | Phase 2 | 21 | First People's Hospital of HangzhouOTHER | 1 | Dec 15, 2015 | clinicaltrials |
| NCT02584699 | Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC | unknown | Phase 2 | 40 | Luhua WangUNKNOWN | 1 | Oct 23, 2015 | clinicaltrials |
| NCT01707329 | Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment | unknown | Phase 2 | 180 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Sep 9, 2015 | clinicaltrials |
| NCT02540824 | Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Sep 4, 2015 | clinicaltrials |
| NCT02535507 | Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Aug 28, 2015 | clinicaltrials |
| NCT01592617 | Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer | unknown | Phase 2 | 45 | Shiga UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01843647 | Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients | unknown | Phase 2 | 100 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02062515 | Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency | unknown | Phase 2 | 30 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02006043 | Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-) | unknown | Phase 2 | 54 | Li ZhangOTHER | 1 | Jul 3, 2015 | clinicaltrials |
| NCT01172925 | Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer(TIDAL) | unknown | Phase 2 | 34 | Hamilton Health Sciences CorporationOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01929200 | Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02027090 | High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease | unknown | Phase 2 | 64 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02430974 | Chemotherapy of NSCLC With or Without Icotinib | unknown | Phase 2 | 50 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Apr 30, 2015 | clinicaltrials |
| NCT02407600 | Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy | unknown | Phase 2 | 150 | Ajeet GajraOTHER | 1 | Apr 3, 2015 | clinicaltrials |
| NCT02407366 | Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 80 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Apr 2, 2015 | clinicaltrials |
| NCT01549093 | Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 90 | Hunan Province Tumor HospitalOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT02387086 | Gefitinib Combined With Thalidomide to Treat NSCLC | unknown | Phase 2 / Phase 3 | 380 | Bai JunOTHER | 0 | Mar 12, 2015 | clinicaltrials |
| NCT02009605 | Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer | unknown | Phase 2 | 30 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02338011 | Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)(EGFR) | unknown | Phase 2 / Phase 3 | 210 | Shanghai Chest HospitalOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01690390 | Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease | unknown | Phase 2 | 180 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Dec 30, 2014 | clinicaltrials |
| NCT01763385 | Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases(TRACTS) | unknown | Phase 2 | 210 | Wu Jieping Medical FoundationOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02319577 | GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial | unknown | Phase 2 | 80 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Dec 18, 2014 | clinicaltrials |
| NCT01784549 | Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease(CONTEST) | unknown | Phase 2 | 168 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT02272127 | Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer | unknown | Phase 2 | 100 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Oct 22, 2014 | clinicaltrials |
| NCT01424709 | Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)(BRAVO) | unknown | Phase 2 | 120 | Tongji UniversityOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT02224547 | Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System | unknown | Phase 2 | 58 | Universitair Ziekenhuis BrusselOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT02215356 | Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT02191059 | Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer | unknown | Phase 2 | 60 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT02146118 | A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma | unknown | Phase 2 | 42 | MedicalLogicINDUSTRY | 1 | May 23, 2014 | clinicaltrials |
| NCT01969955 | Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer | unknown | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT01861223 | Afatinib Plus Nimotuzumb for NSCLC | unknown | Phase 1 / Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02036359 | Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca(Oncology) | unknown | Phase 2 | 76 | National Taiwan University HospitalOTHER | 1 | Jan 15, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Jul 28, 2016source: clinicaltrials